The Department of Health has asked the National Institute for Health and Clinical Excellence (NICE) to produce guidance on using donepezil, galantamine, rivastigmine and memantine in the NHS in ...

BACKGROUND: Donepezil, rivastigmine and galantamine are popular cholinesterase inhibitors used to manage the symptoms of Alzheimer disease and other dementias; regulatory agencies in several countries ...

Early evidence links some Alzheimer’s Disease medications to small cognitive gains in children with autism and low IQ, ...

Older patients prescribed donepezil had a higher risk for hospital admission for rhabdomyolysis than patients prescribed rivastigmine or galantamine, according to a population-based cohort study ...

A drug commonly used to manage symptoms of Alzheimer disease and other dementias -- donepezil -- is associated with a two-fold higher risk of hospital admission for rhabdomyolysis, a painful condition ...

A class of drugs commonly used to treat Alzheimer’s disease and other dementias in nursing home residents has been found to slow cognitive decline over a five-year period in patients diagnosed with ...

We lack a randomized, controlled comparison of the cholinesterase inhibitors. However, if one agent were dramatically more effective or substantially more toxic, the differences would be obvious in ...

People with Alzheimer’s disease who continue taking the drug donepezil (Aricept) do get some benefit even as their symptoms worsen, a new study suggests. While the drug is approved for all stages of ...

Please provide your email address to receive an email when new articles are posted on . This year, Biogen is expected to submit a Biologics License Application to the FDA for its anti-amyloid antibody ...